Security
Onconetix, Inc. Common Stock · ONCO
ONCONASDAQCommon stockCurrentCIK 1782107Updated Nov 6, 2026
Name history
Blue Water Biotech, Inc. · through Dec 18, 2023Blue Water Vaccines Inc. · through Apr 20, 2023
ONCO price & chart
Loading TradingView…
NASDAQ:ONCO on TradingView ↗About the company
We are a commercial stage biotechnology company focused on the research, development, and commercialization of innovative solutions for oncology. Through our acquisition of Proteomedix, which closed on December 15, 2023, we own Proclarix, an in vitro diagnostic test for prostate cancer originally developed by Proteomedix and approved for sale in the European Union under the In Vitro Diagnostic Regulation (“IVDR”), which we anticipate will be marketed in the U.S. as a lab developed test through our license agreement with LabCorp.
In the news
HRT Financial sells $34,299 of Onconetix (NASDAQ:ONCO) stock ↗
Onconetix, Inc. Announces 1-for-5 Reverse Stock Split ↗
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ONCO, WAT, XAGE on Behalf of Shareholders News provided by Halper Sadeh LLP Jul 18, 2025, 11:33 ET Share this article Share to X Share this article Share to X NEW YORK , July 18, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law fi ↗
Recent filings
425 filing
Entry into a Material Definitive Agreement
Items 1.01, 9.01
425 filing
Other Events
Items 8.01, 9.01
DEFA14A filing
Show 5 more recent filings
Other Events
Items 8.01, 9.01
425 filing
ARS filing
DEF 14A filing
PRE 14A filing
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 19,678,868Source | 61,919,418Source | 16,426,341Source | 19,119,036Source | 59,463,955Source | 14,832,086Source | 18,775,711Source | 75,031,599Source | 24,926,638Source | 28,181,563Source | 87,518,032Source | 26,310,447Source |
| Property, Plant and Equipment, NetUSD | 40,388Source | 69,317Source | 28,655Source | 43,809Source | 69,189Source | 31,533Source | 55,805Source | 56,763Source | 37,085Source | 62,896Source | 60,654Source | 14,089Source |
| GoodwillUSD | 18,180,299Source | 38,861,238Source | 9,618,142Source | 18,123,296Source | 36,502,332Source | 10,203,473Source | 16,209,509Source | 46,743,319Source | 18,549,005Source | 27,048,973Source | 55,676,142Source | — |
| Intangible Assets, Net (Excluding Goodwill)USD | — | 21,414,795Source | — | — | 20,310,890Source | — | — | 21,453,555Source | — | — | 25,410,887Source | — |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | — | — | — | — | — | — | — | — | — | — | — | 25,752,659Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 2,552Source | 98,030Source | 2,351Source | 12,156Source | 171,313Source | 43,725Source | 16,293Source | 252,792Source | 296,866Source | 25,717Source | 149,731Source | — |
| Inventory, NetUSD | 151,556Source | 121,834Source | 210,448Source | 153,072Source | 160,272Source | 137,642Source | 155,660Source | 396,312Source | 149,961Source | 64,079Source | 364,052Source | — |
| Assets, CurrentUSD | 1,302,026Source | 1,047,939Source | 6,517,810Source | 930,531Source | 2,035,448Source | 4,329,354Source | 2,420,589Source | 6,294,697Source | 6,066,774Source | 950,267Source | 5,838,271Source | 26,257,741Source |
| Prepaid Expense and Other Assets, CurrentUSD | 311,362Source | 486,580Source | 362,762Source | 481,788Source | 773,322Source | 431,915Source | 671,443Source | 1,181,723Source | 349,293Source | 213,971Source | 770,153Source | — |
| Operating Lease, Right-of-Use AssetUSD | 6,155Source | 160,016Source | 36,734Source | 21,400Source | 179,983Source | 42,726Source | 89,808Source | 109,360Source | 48,774Source | 119,427Source | 148,542Source | — |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 16,303,023Source | 20,896,798Source | 2,956,108Source | 12,765,832Source | 23,956,504Source | 3,083,885Source | 14,258,469Source | 25,293,426Source | 9,160,287Source | 18,571,008Source | 21,877,471Source | 3,922,445Source |
| Stockholders’ equity: | ||||||||||||
| Common Stock, Value, IssuedUSD | 15Source | 83Source | 38Source | 10Source | 228Source | 27Source | 368Source | 228Source | 15Source | 118Source | 228Source | 157Source |
| Additional Paid in CapitalUSD | 141,431,240Source | 119,563,869Source | 152,959,715Source | 135,021,431Source | 49,405,359Source | 148,242,874Source | 132,630,941Source | 49,452,674Source | 147,835,989Source | 127,825,626Source | 49,428,809Source | 42,331,155Source |
| Retained Earnings (Accumulated Deficit)USD | -136,884,245Source | -86,038,875Source | -138,296,736Source | -128,100,543Source | -82,211,470Source | -135,429,433Source | -125,399,597Source | -67,904,766Source | -131,214,558Source | -115,683,621Source | -56,786,194Source | -19,376,500Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -547,098Source | 1,012,557Source | -568,717Source | -385,346Source | -2,378,952Source | -441,200Source | -2,613,128Source | -2,455,546Source | -231,028Source | -2,723,397Source | 2,380,920Source | — |
| Stockholders' Equity Attributable to ParentUSD | — | 33,911,843Source | 13,468,509Source | 5,909,761Source | -35,810,626Source | 11,746,477Source | 3,992,793Source | -21,533,201Source | — | 8,542,627Source | -5,602,028Source | 22,388,002Source |
| Liabilities and EquityUSD | 19,678,868Source | 61,919,418Source | 16,426,341Source | 19,119,036Source | 59,463,955Source | 14,832,086Source | 18,775,711Source | 75,031,599Source | 24,926,638Source | 28,181,563Source | 87,518,032Source | 26,310,447Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 16,303,023Source | 17,356,101Source | 2,943,793Source | 12,692,188Source | 20,603,559Source | 3,065,574Source | 14,039,308Source | 21,433,697Source | 9,135,925Source | 18,290,129Source | 17,190,247Source | 3,922,445Source |
| Operating Lease, Liability, CurrentUSD | 6,155Source | 127,738Source | 24,419Source | 21,400Source | 119,474Source | 24,415Source | 89,808Source | 62,480Source | 24,412Source | 119,427Source | 74,252Source | — |
| Accounts Payable, CurrentUSD | 1,804,163Source | 4,112,392Source | 1,844,861Source | 2,581,608Source | 3,169,727Source | 1,532,885Source | 2,581,743Source | 4,251,394Source | 1,757,695Source | 3,787,564Source | 5,295,114Source | 1,499,296Source |
| Operating Lease, Liability, NoncurrentUSD | — | 32,279Source | 12,315Source | — | 60,509Source | 18,311Source | — | 46,880Source | 24,362Source | — | 74,290Source | — |
| Deferred Income Tax Liabilities, NetUSD | — | 2,867,794Source | — | — | 2,805,816Source | — | — | 2,743,246Source | — | — | 3,073,781Source | — |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | — | 7,110,777Source | — | — | 7,081,992Source | — | — | 7,035,289Source | — | — | 7,006,504Source | — |
| Additional Financial Items | ||||||||||||
| Accounts Receivable, after Allowance for Credit LossUSD | 3,000Source | 98,000Source | — | 12,000Source | — | 40,000Source | 16,000Source | 26,000Source | 300,000Source | 26,000Source | 87,000Source | — |
| Accrued Liabilities, CurrentUSD | 476,289Source | 1,337,663Source | 249,607Source | 894,986Source | 1,438,872Source | 279,121Source | 1,159,764Source | 1,936,014Source | 341,881Source | 888,988Source | 2,199,867Source | 2,409,128Source |
| Deferred Tax Liabilities, NetUSD | — | — | — | — | — | — | — | — | — | — | 3,073,781Source | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | — | — | — | — | -37,409,694Source | — |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | — | — | — | — | 5,398Source | 4,748Source | 15,170Source | 731,345Source | 43,937Source | — |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 22,305Source | 29,256Source | 74,267Source | 438,653Source | 329,760Source | 1,974,566Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | -270,735Source | -9,453Source | 268,685Source | -116,676Source | 62,286Source | — |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | -11,654Source | 91,019Source | 73,720Source | 62,273Source | 315,828Source | — |
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | -224,779Source | -261,362Source | -1,093,655Source | -1,477,075Source | 3,372,648Source | 1,093,913Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | — | -1,045,181Source | -12,593Source | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -2,121,481Source | -1,999,680Source | -9,678,390Source | -10,495,816Source | -13,581,018Source | -8,698,860Source |
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | — | — | — | — | — | — | — | — | — | — | -1,056,578Source | — |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | — | — | — | -28,471Source | -8,649,035Source | -9,339Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | — | — | — | 28,471Source | 3,300Source | 9,339Source |
| Cash flows from financing activities: | ||||||||||||
| Payments for Repurchase of Common StockUSD | — | — | — | — | — | — | — | — | — | — | — | 566,810Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 631,788Source | 2,870,254Source | 14,452,686Source | 6,743,110Source | 1,035,060Source | 32,532,384Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | -1,504,582Source | 930,693Source | 4,574,154Source | -3,907,835Source | -21,198,324Source | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 836,556Source | 341,495Source | 5,942,249Source | 283,515Source | 3,716,072Source | 1,577,193Source | 5,220,654Source | 646,500Source | 4,554,335Source | 25,752,659Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | — | 21,162Source | 766,330Source | — | — | — |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | — | — | — | — | -14,889Source | 60,119Source | -200,142Source | -126,658Source | -3,331Source | — |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | 9,795Source | 45,634Source | 7,359Source | 30,982Source | 22,305Source | 29,256Source | 74,267Source | 438,653Source | 329,760Source | 700,000Source |
| Amortization of Intangible AssetsUSD | — | — | — | 198,000Source | — | — | — | — | — | 709,042Source | 36,812Source | — |
| AssetAcquisitionContingentConsiderationLiabilityUSD | — | — | — | — | — | — | — | — | — | — | — | 8,000Source |
| Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to SettlementUSD | — | — | 284,647Source | — | — | 487,485Source | — | — | 795,594Source | — | — | — |
| DepreciationUSD | — | — | — | — | — | — | — | — | 15,000Source | 22,000Source | 7,000Source | 6,752Source |
| Fair Value, Option, Changes in Fair Value, Gain (Loss)USD | — | — | — | — | — | — | — | — | — | — | -91,967Source | — |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | — | — | — | — | — | — | — | -2,472Source | -17,283Source | — | — | — |
| Gain (Loss) on Sale of Assets and Asset Impairment ChargesUSD | — | — | — | — | — | — | — | — | — | — | -267,019Source | — |
| Gain (Loss) Related to Litigation SettlementUSD | — | — | — | — | — | — | — | 944,694Source | — | 5,282Source | — | — |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | -5,384,719Source | — | — | — | — | — | -5,384,719Source | — | -490,000Source | — |
| General and Administrative ExpenseUSD | — | — | — | — | — | — | — | — | — | — | — | 9,351,552Source |
| GoodwillUSD | — | — | 18,180,299Source | 38,861,238Source | 9,618,142Source | 18,123,296Source | 10,203,473Source | 16,209,509Source | 18,549,005Source | 27,048,973Source | 55,676,142Source | — |
| Goodwill, Impairment LossUSD | — | — | — | — | 486,000Source | 594,000Source | 8,134,000Source | 10,918,000Source | 11,512,000Source | 32,347,000Source | 14,700,000Source | — |
| Impairment of Intangible Assets (Excluding Goodwill)USD | — | — | — | — | — | — | — | — | — | 10,279,796Source | 14,687,346Source | — |
| Impairment of Intangible Assets, Finite-livedUSD | — | — | — | — | — | — | — | — | — | 356,637Source | — | — |
| Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)USD | — | — | — | — | — | — | — | — | — | — | 14,687,346Source | — |
| Income Tax Expense (Benefit)USD | — | — | — | -56,384Source | — | — | — | — | 525Source | -1,045,180Source | -12,593Source | 3,158,873,000,000Source |
| InterestExpenseNonoperatingUSD | — | — | 300,069Source | 231,656Source | 4,389Source | 223,097Source | 2,244Source | 223,592Source | 751,005Source | 873,433Source | — | — |
| Inventory Write-downUSD | — | — | — | — | — | — | — | — | — | — | 1,152,369Source | — |
| Investment Income, InterestUSD | — | — | — | — | — | — | — | — | 2Source | 18Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | -8,783,702Source | -3,827,405Source | -2,867,303Source | -2,372,442Source | -4,214,875Source | -8,545,885Source | -14,032,342Source | -58,691,023Source | — | -13,419,830Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | -8,783,702Source | -3,827,405Source | -2,867,303Source | -2,700,946Source | -4,214,875Source | -9,715,976Source | -15,530,937Source | -58,897,427Source | -37,409,694Source | -13,516,189Source |
| Nonoperating Income (Expense)USD | — | — | -6,714,460Source | -1,237,922Source | -136,513Source | -437,024Source | 6,010,926Source | 4,024,944Source | 3,825,039Source | -3,247,448Source | — | — |
| Operating ExpensesUSD | — | — | 2,338,136Source | 2,751,281Source | 2,735,093Source | 2,005,921Source | 10,224,146Source | 12,616,661Source | 18,489,769Source | 57,543,853Source | 34,907,430Source | 13,481,240Source |
| Other Nonoperating Income (Expense)USD | — | — | -8,063Source | 44,988Source | 4,747Source | -22,660Source | -16,810Source | -5,363Source | 226,041Source | 168,746Source | -1,387,692Source | — |
| Payments of Financing CostsUSD | — | — | — | — | — | — | — | — | — | 400,000Source | — | — |
| Pension Cost (Reversal of Cost)USD | — | — | — | — | — | — | — | — | — | -48,423Source | 13,875Source | — |
| Proceeds from Contributed CapitalUSD | — | — | — | — | — | — | — | — | — | 935,625Source | — | — |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | — | 5,026,617Source | 6,391,655Source | 685,282Source | — | — |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | — | — | — | 163Source | 459Source | 1,655Source |
| Amortization | — | — | — | — | — | — | — | — | — | — | — | — |
| Gain (Loss) on Termination of Lease | — | — | —Source | — | — | — | — | — | — | — | — | — |
| Goodwill and Intangible Asset Impairment | — | — | — | — | — | — | — | —Source | — | — | — | — |
| Revenue from Contract with Customer, Including Assessed Tax | — | — | — | —Source | — | — | — | — | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | — | — | — | — | — | — | 815,371Source | 2,524,116Source | 58,465Source | — |
| Cost of Goods and Services Sold | — | — | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | — |
| Selling, General and Administrative ExpenseUSD | — | — | 2,341,347Source | 2,641,916Source | 2,245,653Source | 1,523,591Source | 2,039,328Source | 1,674,206Source | 7,043,902Source | 11,231,982Source | 14,770,678Source | — |
| Operating Income (Loss)USD | — | — | -2,069,242Source | -2,645,867Source | -2,730,790Source | -1,935,418Source | -10,225,801Source | -12,570,829Source | -17,856,856Source | -56,488,755Source | -36,034,595Source | -13,481,240Source |
| Other Nonoperating Income (Expense)USD | — | — | -8,063Source | 44,988Source | 4,747Source | -22,660Source | -16,810Source | -5,363Source | 226,041Source | 168,746Source | -1,387,692Source | — |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -8,783,702Source | -3,883,789Source | -2,867,303Source | -2,372,442Source | -4,214,875Source | -8,545,885Source | -14,031,817Source | -59,736,203Source | -37,422,287Source | — |
| Income Tax Expense (Benefit)USD | — | — | — | -56,384Source | — | — | — | — | 525Source | -1,045,180Source | -12,593Source | 3,158,873,000,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -8,783,702Source | -3,827,405Source | -2,867,303Source | -2,372,442Source | -4,214,875Source | -8,545,885Source | -14,032,342Source | -58,691,023Source | — | -13,419,830Source |
| Earnings Per Share, BasicUSD per share | — | — | -6.25Source | -249.08Source | -1.28Source | -237.91Source | -6.71Source | -227.25Source | -16.56Source | -21.45Source | -2.19Source | -1.1Source |
| Earnings Per Share, DilutedUSD per share | — | — | -6.25Source | -249.08Source | -1.28Source | -237.91Source | -6.71Source | -227.25Source | -16.56Source | -21.45Source | -2.19Source | -1.1Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 1,405,469Source | 15,366Source | 2,242,770Source | 11,353Source | 628,528Source | 42,755Source | 937,690Source | 2,745,564Source | 17,111,374Source | 12,271,449Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 1,405,469Source | 15,366Source | 2,242,770Source | 11,353Source | 628,528Source | 42,755Source | 937,690Source | 2,745,564Source | 17,111,374Source | 12,271,449Source |
| Interest Expense (non-operating)USD | — | — | 300,069Source | 231,656Source | 4,389Source | 223,097Source | 2,244Source | 223,592Source | 751,005Source | 873,433Source | — | — |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | — | 198,000Source | — | — | — | — | — | 709,042Source | 36,812Source | — |
| Common Stock, Dividends, Per Share, DeclaredUSD per share | — | — | — | — | — | — | — | — | — | — | — | 1.23Source |
| Costs and ExpensesUSD | — | — | — | — | — | — | — | — | 35,000Source | 35,000Source | — | — |
| Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to SettlementUSD | — | — | 284,647Source | — | — | 487,485Source | — | — | 795,594Source | — | — | — |
| Depreciation, Depletion and Amortization, NonproductionUSD | — | — | — | — | — | — | 5,398Source | 4,748Source | 15,170Source | 731,345Source | — | — |
| Fair Value, Option, Changes in Fair Value, Gain (Loss)USD | — | — | — | — | — | — | — | — | — | — | -91,967Source | — |
| Gain (Loss) Related to Litigation SettlementUSD | — | — | — | — | — | — | — | 944,694Source | — | 5,282Source | — | — |
| General and Administrative ExpenseUSD | — | — | — | — | — | — | — | — | — | — | — | 9,351,552Source |
| Goodwill, Impairment LossUSD | — | — | — | — | 486,000Source | 594,000Source | 8,134,000Source | 10,918,000Source | 11,512,000Source | 32,347,000Source | 14,700,000Source | — |
| Gross ProfitUSD | — | — | 268,894Source | 105,414Source | 4,303Source | 70,503Source | -1,655Source | 45,832Source | 632,913Source | 1,055,098Source | -1,127,165Source | — |
| Income (Loss) Attributable to Parent, before TaxUSD | — | — | — | — | — | — | — | — | — | — | -37,422,287Source | — |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | — | — | -14,454,877Source | -58,988,309Source | -37,106,599Source | — |
| Interest ExpenseUSD | — | — | — | — | — | — | — | — | — | — | 671,625Source | — |
| Interest Expense, DebtUSD | — | — | — | 153,302Source | — | 200,000Source | 2,000Source | 200,000Source | — | — | 700,000Source | — |
| Investment Income, InterestUSD | — | — | — | — | — | — | — | — | 2Source | 18Source | — | — |
| Labor and Related ExpenseUSD | — | — | — | — | — | — | — | — | — | — | 209,000Source | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | -8,783,702Source | -3,827,405Source | -2,867,303Source | -2,700,946Source | -4,214,875Source | -9,715,976Source | -15,530,937Source | -58,897,427Source | -37,409,694Source | -13,516,189Source |
| Nonoperating Income (Expense)USD | — | — | -6,714,460Source | -1,237,922Source | -136,513Source | -437,024Source | 6,010,926Source | 4,024,944Source | 3,825,039Source | -3,247,448Source | — | — |
| Operating ExpensesUSD | — | — | 2,338,136Source | 2,751,281Source | 2,735,093Source | 2,005,921Source | 10,224,146Source | 12,616,661Source | 18,489,769Source | 57,543,853Source | 34,907,430Source | 13,481,240Source |
| Other Cost of Operating RevenueUSD | — | — | — | — | — | — | — | — | — | — | 31,000Source | — |
| Other ExpensesUSD | — | — | — | 19,000Source | — | — | — | — | 0Source | 18,000Source | 50,000Source | — |
| Other General ExpenseUSD | — | — | — | — | — | — | — | — | — | — | 35,000Source | — |
| Other Operating IncomeUSD | — | — | — | — | — | — | — | — | — | — | — | 61,410Source |
| Preferred Stock Dividends and Other AdjustmentsUSD | — | — | — | — | — | — | — | — | — | — | — | 96,359Source |
| Research and Development ExpenseUSD | — | — | — | 109,365Source | — | — | — | 24,455Source | — | 154,359Source | 1,949,406Source | 4,129,688Source |
| Total Revenue | — | — | —Source | —Source | —Source | —Source | —Source | —Source | — | — | — | — |
| Current Income Tax Expense (Benefit) | — | — | — | —Source | — | — | — | — | — | — | — | — |
| Other Income | — | — | — | —Source | — | — | — | — | — | — | — | — |
| Revenue from Contract with Customer, Including Assessed Tax | — | — | — | —Source | — | — | — | — | — | — | — | — |
Offerings
Registration 333-298259
Registration 333-296615
Registration 333-291256
Registration 333-295376
Filing attachments
ea030972301ex99-1.htm · 8-K · 2026-10-26
Exhibit 99.1 Onconetix Announces Reverse Stock Split CINCINNATI, Ohio, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) (the “Company”), today announced that its Board of Directors has approved a one-for-ten (1-for-10) reverse stock split of the Company’s outstanding common stock. The reverse split is expected to become effective at 12:01 a.m. Eastern Time on November 6, 2026. The Company’s common stock has been assigned a new CUSIP number, 68237Q500, in connection with the rev…
Read attachment ↗ea030515701ex99-1.htm · DEFA14A · 2026-09-14
EX-99.1 4 ea030515701ex99-1.htm PRESS RELEASE, DATED SEPTEMBER 14, 2026 Exhibit 99.1 Filed by Onconetix, Inc. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-6(b) under the Securities Exchange Act of 1934 Subject Company: Onconetix, Inc. Commission File No.: 001-41294 Date: September 14,2026 Onconetix Provides Strategic Bridge Financing to Realbotix LLC in Support of Pending Acquisition Initial Advance of $2.5 Million to Realbotix LLC to S…
Read attachment ↗ea030515701ex99-1.htm · 8-K · 2026-09-14
EX-99.1 4 ea030515701ex99-1.htm PRESS RELEASE, DATED SEPTEMBER 14, 2026 Exhibit 99.1 Filed by Onconetix, Inc. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-6(b) under the Securities Exchange Act of 1934 Subject Company: Onconetix, Inc. Commission File No.: 001-41294 Date: September 14,2026 Onconetix Provides Strategic Bridge Financing to Realbotix LLC in Support of Pending Acquisition Initial Advance of $2.5 Million to Realbotix LLC to S…
Read attachment ↗ea029154301ex99-1.htm · 8-K · 2026-05-19
EX-99.1 3 ea029154301ex99-1.htm PRESS RELEASE, DATED MAY 19, 2026 Exhibit 99.1 Onconetix, Inc. Announces 1-for-10 Reverse Stock Split CINCINNATI, Ohio, May 19, 2026 (GLOBE NEWSWIRE) - Onconetix, Inc. (NASDAQ: ONCO) (“Onconetix” or the “Company”), a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for oncology, today announced that its Board of Directors (the “Board of Directors” or “Board”) has approved a 1-for-10 r…
Read attachment ↗ea029073901ex99-1.htm · 8-K · 2026-05-14
EX-99.1 2 ea029073901ex99-1.htm PRESS RELEASE, DATED MAY 13, 2026 Exhibit 99.1 Onconetix Reports Q1 2026 Progress at Proteomedix AG, Including Two New Peer-Reviewed Publications and Initiation of U.S. Validation Study New Clinical Data Reinforce Proclarix ® Performance in Reducing Overdiagnosis and Unnecessary Biopsies; Multi-Center PRIME Study Initiated in Collaboration with Labcorp; European Commercial Expansion Advances CINCINNATI, Ohio, May 13, 2026 (GLOBE NEWSWIRE) - Onconetix, Inc. …
Read attachment ↗ea028356901ex99-1.htm · 8-K · 2026-03-27
EX-99.1 3 ea028356901ex99-1.htm PRESS RELEASE, DATED MARCH 23, 2026 Exhibit 99.1 Onconetix, Inc. Announces 1-for-5 Reverse Stock Split CINCINNATI, Ohio, March 23, 2026 (GLOBE NEWSWIRE) -- Onconetix, Inc. (NASDAQ: ONCO) (“Onconetix” or the “Company”), a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men’s health and oncology, today announced that its Board of Directors (the “Board of Directors” or “Board”) has a…
Read attachment ↗